Cellular & Molecular Immunology

(The H4-Index of Cellular & Molecular Immunology is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications1259
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death821
NLRP3 inflammasome activation and cell death530
Tumor-infiltrating lymphocytes in the immunotherapy era432
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells378
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities325
An update on the regulatory mechanisms of NLRP3 inflammasome activation322
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70278
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity260
Macrophages and the maintenance of homeostasis208
Neutrophils in chronic inflammatory diseases201
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients196
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases195
The blood–brain barrier in systemic infection and inflammation194
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors191
Gut microbiome, liver immunology, and liver diseases188
Cancer immunotherapy with γδ T cells: many paths ahead of us188
Dendritic cell migration in inflammation and immunity178
Unique immunological profile in patients with COVID-19173
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids173
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron172
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells163
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients159
New insights into the evasion of host innate immunity by Mycobacterium tuberculosis155
Metabolism of tissue macrophages in homeostasis and pathology142
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response137
SARS-CoV-2-specific T cells in infection and vaccination131
Manganese salts function as potent adjuvants126
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer122
Activation or exhaustion of CD8+ T cells in patients with COVID-19116
The cutting-edge progress of immune-checkpoint blockade in lung cancer110
Tumor-associated myeloid cells: diversity and therapeutic targeting108
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors107
Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients107
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy106
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response105
Immunological mechanisms and therapeutic targets of fatty liver diseases104
Dendritic cells in cancer immunology103
Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases102
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation95
Human immunology and immunotherapy: main achievements and challenges94
ACOD1 in immunometabolism and disease94
Phages and their potential to modulate the microbiome and immunity92
Neutralizing antibodies for the prevention and treatment of COVID-1991
New insights into the cell- and tissue-specificity of glucocorticoid actions88
Neutrophils in liver diseases: pathogenesis and therapeutic targets85
Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment83
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies83
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods83
Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions77
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection77
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant76
USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy75
Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm75
Immunopathobiology and therapeutic targets related to cytokines in liver diseases75
Expansion of atypical memory B cells is a prominent feature of COVID-1972
Impact of intracellular innate immune receptors on immunometabolism70
Autoimmmune hepatitis69
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor69
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia69
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract68
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals66
“Autoinflammatory psoriasis”—genetics and biology of pustular psoriasis66
Microglia as hackers of the matrix: sculpting synapses and the extracellular space65
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice64
The essential functions of mitochondrial dynamics in immune cells64
Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells64